AIM
VKTX icon

AXA Investment Managers’s Viking Therapeutics VKTX Stock Holding History

AXA Investment Managers’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.41M Buy
+53,591
New +$1.6M ﹤0.01% 832

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AXA Investment Managers's VKTX Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Viking Therapeutics (VKTX) in Q3 2025: 53,591 shares worth $1.41M. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings.

370 funds tracked by Wall St. Rank hold VKTX as of Q3 2025.

  • AXA Investment Managers held 53,591 shares of Viking Therapeutics worth $1.41M as of Q3 2025.
  • Viking Therapeutics was a new AXA Investment Managers position in Q3 2025.
  • Viking Therapeutics made up ﹤0.01% of AXA Investment Managers's portfolio in Q3 2025, its #832 holding.
  • 370 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.